Liverpool Women's NHS Foundation Trust is looking to purchase a patient monitoring system that will have the capability to predict the future risk of late-onset sepsis in neonates.

The system would support data from clinical trials to demonstrate the reduction in mortality. The system would also need to be compatible with the Trust's existing patient monitoring systems manufactured by Philips Medical.

To the best of our knowledge there is only one system currently available on the market, which has patent protected technology.

The Trust welcomes expressions of interest from any suppliers who can demonstrate their capability to meet the Trust's requirements.